D
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Price:
10.885
USD
0.14%
Market Closed
Market Cap:
$264.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
US |
|
L
|
Leopard Lake Gold Corp
CNSX:LP
|
CA |
|
Bpost SA
XBRU:BPOST
|
BE |
|
Webuild SpA
MIL:WBD
|
IT |
|
S
|
Sanko Diecasting Thailand PCL
SET:SANKO
|
TH |
|
F
|
Fujifilm Holdings Corp
SWB:FJI
|
JP |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
US |
|
A
|
Acacia Research Corp
F:AZG2
|
US |
|
C
|
Chubu Electric Power Co Inc
F:0C2
|
JP |
|
Wilh Wilhelmsen Holding ASA
OTC:WLHSF
|
NO |
|
L
|
Lithium Ionic Corp
OTC:LTHCF
|
CA |
|
M
|
Matsuoka Corp
TSE:3611
|
JP |
|
T
|
Thermo Fisher Scientific Inc
BMV:TMO
|
US |
|
Lucid Group Inc
NASDAQ:LCID
|
US |
|
C
|
Construction JSC No 9
VN:VC9
|
VN |
|
A
|
Affinity Metals Corp
CNSX:AFF
|
CA |
|
P
|
Paladin Energy Ltd
XHAM:PUR
|
AU |
|
DNB Bank ASA
F:D1N
|
NO |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of DMAA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DMAA
Multiples-Based Value
Base Case
Not Available